Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Common medication-related gastrointestinal symptoms usually occur shortly after injection, improve between doses, and gradually diminish with continued use
If you are someone who gets clumsy when tired, prepare your syringe earlier in the day and store it in the refrigerator until injection time
Tirzepatide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those diagnosed with multiple endocrine neoplasia syndrome type 2, due to a theoretical risk of thyroid tumors based on animal studies
The key risks across both compounds include: Gastrointestinal adverse events (nausea, vomiting, diarrhoea), most pronounced during dose escalation Potential for gallbladder disease, consistent with rapid weight reduction Retatrutide-specific: dysesthesia and elevated resting heart rate [3] Both compounds: risk of hypoglycaemia when used in combination with insulin or sulphonylureas in diabetic models All compounds available through Sempica are strictly for research use by qualified professionals
Do coughing and deep breathing exercises
US$ 21.36
US$ 29.60
US$ 29.42
US$ 28.71
US$ 28.89
US$ 27.96
